SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-010926
Filing Date
2018-08-09
Accepted
2018-08-09 15:59:43
Documents
61
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fcsc-2018063010qx2.htm 10-Q 996462
2 EXHIBIT 31 fcsc-2018630ex31.htm EX-31 9871
3 EXHIBIT 32 fcsc-2018630ex32.htm EX-32 6934
10 fcsccolorlogoa09.jpg GRAPHIC 74382
11 pipelinegraph8082018.jpg GRAPHIC 55553
  Complete submission text file 0001628280-18-010926.txt   6081607

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fcsc-20180630.xml EX-101.INS 1229401
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20180630.xsd EX-101.SCH 44064
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20180630_cal.xml EX-101.CAL 53153
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20180630_def.xml EX-101.DEF 279547
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fcsc-20180630_lab.xml EX-101.LAB 582688
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20180630_pre.xml EX-101.PRE 394125
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 181004904
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences